Sucampo Pharmaceuticals Stock Buy Rating target price $9.00 : Sucampo Pharmaceuticals (NASDAQ: SCMP)‘s stock had its “buy” rating restated by equities researchers at Cantor Fitzgerald in a report issued on Thursday, AnalystRatings.Net reports. They currently have a $9.00 target price on the stock.
Showing posts with label Sucampo Pharmaceuticals. Show all posts
Showing posts with label Sucampo Pharmaceuticals. Show all posts
Thursday, 18 April 2013
Subscribe to:
Posts (Atom)